You are here:

Boehringer Ingelheim Ltd

Name SMC ID No Status Sub. Type
 
afatinib (Giotrif) 1174/16 Not Recommended Non submission
afatinib (Giotrif) 920/13 Accepted Full submission
alteplase (Actilyse Cathflo 2mg) 717/11 Restricted Abbreviated Submission
alteplase (Actilyse) 714/11 Accepted Full submission
Alteplase (Actilyse®) 87/04 Restricted Full submission
dabigatran (Pradaxa) 672/11 Accepted Full submission
dabigatran Etexilate (Pradaxa) 466/08 Accepted Full submission
dabigatran etexilate (Pradaxa) 995/14 Accepted Full submission
empagliflozin (Jardiance) 993/14 Superseded Full submission
empagliflozin/metformin (Synjardy) 1092/15 Restricted Abbreviated Submission
idarucizumab (Praxbind) 1178/16 Accepted Full submission
linagliptin (Trajenta) 850/13 Restricted Full submission
linagliptin (Trajenta) 850/13 Accepted Resubmission
linagliptin (Trajenta) 746/11 Restricted Full submission
linagliptin + metformin (Jentadueto) 1057/15 Restricted Abbreviated Submission
linagliptin+metformin (Jentadueto) 841/13 Restricted Abbreviated Submission
nevirapine (Viramune) 760/12 Accepted Abbreviated Submission
nintedanib (Ofev) 1076/15 Restricted Full submission
nintedanib (Vargatef) 1027/15 Accepted Full submission
olodaterol 2.5 microgram solution for inhalation (Striverdi® Respimat®) 974/14 Not Recommended Full submission
olodaterol respimat (Striverdi Respimat) 974/14 Accepted Resubmission
pramipexole (Mirapexin) 247/06 Accepted Full submission
pramipexole (Mirapexin) 580/09 Accepted Abbreviated Submission
telmisartan (Micardis) 631/10 Not Recommended Non submission
Telmisartan/hydrochlorothiazide (MicardisPlus®) 39/03 Restricted Full submission
tiotropium (Spiriva Respimat) 411/07 Accepted Abbreviated Submission
tiotropium (Spiriva-Respimat) 411/07 Restricted Abbreviated Submission
Tiotropium bromide (Spiriva®) 19/02 Accepted Full submission
tiotropium, 2.5 microgram, solution for inhalation (Spiriva® Respimat®) 1028/15 Accepted Full submission
tiotropium/olodaterol (Spiolto Respimat) 1099/15 Accepted Abbreviated Submission
tipranavir (Aptivus) 100mg/ml oral solution 602/10 Restricted Abbreviated Submission
tipranavir (Aptivus) 250mg soft capsule 616/10 Restricted Abbreviated Submission
Tipranavir (Aptivus®) 226/05 Not Recommended Full submission
tipranavir, 250 mg capsule (Aptivus) 226/06 Restricted Resubmission

Back